Related posts

Weekly 52-Week Low (or 52-Week High): ELD-T, SIL-T, AMM-T, DIAM-T and More 52-Week Highs and Lows (Jul 10-16)Stocks largely flatMost Anticipated Earnings: BLDP-T, BOS-T and more Canadian Companies Reporting Earnings this Week (May 06-10)
Investor Insights

This summary was created by AI, based on 12 opinions in the last 12 months.

The experts have mixed opinions about WELL Health Technologies. Some believe that the company is displaying growth and operating in a fast-growing niche, while others are concerned about the lack of profitability and bottom line performance. However, there is consensus that the healthcare sector presents opportunities for efficiency. The stock has had a strong start in 2023, with minimal impacts from inflation and supply chain issues, and has a high recurring revenue with organic growth. Overall, the reviews indicate a cautious optimism about the company's potential.

Consensus
Cautious
Valuation
Fair Value
RISKY

Small cap. It would move with a major catalyst like institutional interest, a major contract, or a merger. Otherwise, it's just not on the radar. People own these hoping for a home run, but have to look at your opportunity cost.

Healthcare
HOLD

Increased 2024 guidance. 98% recurring revenue which is very attractive. Not a cheap valuation, would recommend holding, or buying on weakness. A good "small position" in portfolio. 

Healthcare
Unspecified

It is a digital health company. The CEO ran a previous company which did very well. Well Health did well during Covid and made a lot of acquisitions, but hasn't done well since Covid. He is not interested because of lack of profitability and ROC is not as high as he is looking for. He respects the company which has done a good job on the topline but needs a better bottom line. Analysts seem to like it since they make lots of money from it. 

Healthcare
BUY

Healthcare is a good theme and the sector needs to be more efficient so opportunities lie ahead. Strongly likes this.

Healthcare
BUY
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

In regards to WELL's business update we think it provided a positive development. Two Canadian clinics were added in Q4 generating approximately $28 million in annualized revenues for total consideration of less than $400,000 and are expected to positively contribute to EBITDA in 2024. We like this news and should help WELL's Q4 earnings. Additionally, the company is focussed on improving cost efficiencies and is making progress in pursuing oppurtunities in its pipeline. We like WELL as a small cap name that is displaying growth and operates in a fast growing niche. 
Unlock Premium - Try 5i Free

Healthcare
DON'T BUY

He doesn't follow this. They aren't earning money now, not positive yet. Has no reason to buy it, but he doesn't know this industry well.

Healthcare
COMMENT

He is not too familiar with the company but technically there has been quite a drop from its top two or three years ago, and it doesn't look that great right now. It is below its various moving averages and there is quite a lot of active trading. The recent big reversal after the rally is a bad sign. Don't buy right now - wait until $3.50. Look at the bottom line and top line sales.

Healthcare
BUY

Another strong quarter with meaningful new wins. He models 43% revenue growth, 63% EPS growth. 13x 2024 earnings. Less appetite for stocks when bond yields are high, people are afraid. Makes sense at these levels.

Healthcare
BUY

Growing both organically and by acquisition, now just shy of $1B in revenue. Stock's pulled back, still a fairly attractive valuation. Expects a takeover down the road.

Healthcare
BUY ON WEAKNESS
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

We would look at growth rate and forward price/earnings ratios here. Right now WELL is 21X. if we shift earnings to F2024 rather than F2023 it drops to 15X. Considering its history and management and potential, we could see this rising to 20X again, giving 30%+ upside potential if earnings come in as expected. Thus, we would be comfortable buying at the $4 to $4.20. 
Unlock Premium - Try 5i Free

Healthcare
BUY ON WEAKNESS
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

The stock has performed well this year - it was as high as +~110% year-to-date, and we see some consolidation here as being healthy. We do not see any specific news that would cause the share price to drop. At a 14.2X forward P/E and expectations for strong growth going forward, we would consider it buyable, however, we would like to see the price find support before entering here. 
Unlock Premium - Try 5i Free

Healthcare
WAIT

Shares recently dropped over disappointing margins and profits, but they are the best in telehealth. Also, they made puzzling acquisitions. But the CEO has a great track record and blue-chop investors are involved. The stock isn't going anywhere, but the market wants to see better profits.

Healthcare
BUY
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research.

WELL is up 84% YTD and not that far from its 52-week high. It ran up hard this year and the drop does look like profit-taking to us since there really was no negative news. We would consider it buyable today. For the Canadian sector we see it as quite attractive.
Unlock Premium - Try 5i Free

Healthcare
BUY

It has had a very strong start to 2023 and has had minimal impacts from inflation and supply chain issues. It has 95% recurring revenue and organic growth of 21% year over year. Trades at 13.3 X EBITDA.

Healthcare
BUY
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research.

2024  Expectations :

Q4 EPS 3.7c; revenue $146.1M. 

2022 EPS 12c; revenue $538.5M

2023 EPS 21c; revenue $621M

We would consider it a buy today. 
Unlock Premium - Try 5i Free

Healthcare
Showing 1 to 15 of 46 entries

WELL Health Technologies(WELL-T) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 7

Neutral - Hold Signals / Votes : 1

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 9

Stockchase rating for WELL Health Technologies is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

WELL Health Technologies(WELL-T) Frequently Asked Questions

What is WELL Health Technologies stock symbol?

WELL Health Technologies is a Canadian stock, trading under the symbol WELL-T on the Toronto Stock Exchange (WELL-CT). It is usually referred to as TSX:WELL or WELL-T

Is WELL Health Technologies a buy or a sell?

In the last year, 9 stock analysts published opinions about WELL-T. 7 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for WELL Health Technologies.

Is WELL Health Technologies a good investment or a top pick?

WELL Health Technologies was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for WELL Health Technologies.

Why is WELL Health Technologies stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is WELL Health Technologies worth watching?

9 stock analysts on Stockchase covered WELL Health Technologies In the last year. It is a trending stock that is worth watching.

What is WELL Health Technologies stock price?

On 2024-07-23, WELL Health Technologies (WELL-T) stock closed at a price of $4.85.